Published ahead of print on January 14, 2005, doi:10.1165/rcmb.2004-0321OC
Am. J. Respir. Cell Mol. Biol., Volume 32, Number 4, April 2005, 334-341
A more recent version of this article appeared on April 1, 2005
Submitted on October 8, 2004
Revised on January 13, 2005
Induction of human airway smooth muscle apoptosis by neutrophils and neutrophil elastase
Ute Oltmanns1, Maria B Sukkar1, Shaoping Xie1, Matthias John2, and Kian Fan Chung1*
1 Department of Thoracic Medicine, National Heart and Lung Institution, London, United Kingdom,
2 Department of Pneumology, Charite University Hospital, Berlin, Germany
* To whom correspondence should be addressed. E-mail: f.chung{at}imperial.ac.uk.
Neutrophils are an important component of airway inflammation and may interact with human airway smooth muscle cells (HASMC). We investigated the effect of neutrophils and of neutrophil-derived proteases on HASMC survival. When coincubated with neutrophils (0.1-1x106 cells/ml), attachment of human ASMC was reduced to 12.3 ± 4.3% compared to untreated controls after 72 hours. HASMC showed nuclear condensation and fragmentation (41.6 ± 8.1% compared to baseline of 3.1 ± 0.4%), and the biochemical markers of apoptosis, annexin V-binding (9.7 ± 0.7%; baseline 1.1 ± 0.3%) and cleaved caspase-3 expression, were observed. The proteolytic activity released by neutrophils was essential for the pro-apoptotic effect because inhibition of elastase activity by 1-antitrypsin and MeOSuc-Ala-Ala-Pro-Ala-CMK (MSACK) reduced HASMC apoptosis. Human neutrophil elastase (0.1-3µg/ml) induced apoptosis of HASMC, as well as other neutrophil serine proteases, cathepsin G and proteinase 3. Fibronectin degradation products were present in HASMC supernatants exposed to neutrophil-conditioned media and to neutrophil elastase. The local release of proteases from neutrophils present in airway smooth muscle cells may lead to HASMC apoptosis as a result of matrix degradation and loss of cell attachment. This may limit pathological changes such as ASMC hyperplasiaand ECM deposition seen in airway remodeling.
This article has been cited by other articles:

|
 |

|
 |
 
S. Salinthone, M. Ba, L. Hanson, J. L. Martin, A. J. Halayko, and W. T. Gerthoffer
Overexpression of human Hsp27 inhibits serum-induced proliferation in airway smooth muscle myocytes and confers resistance to hydrogen peroxide cytotoxicity
Am J Physiol Lung Cell Mol Physiol,
November 1, 2007;
293(5):
L1194 - L1207.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. An, T. R. Bai, J. H. T. Bates, J. L. Black, R. H. Brown, V. Brusasco, P. Chitano, L. Deng, M. Dowell, D. H. Eidelman, et al.
Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma
Eur. Respir. J.,
May 1, 2007;
29(5):
834 - 860.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Sabroe, L. C. Parker, D. H. Dockrell, D. E. Davies, S. K. Dower, and M. K. B. Whyte
Targeting the Networks that Underpin Contiguous Immunity in Asthma and Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
February 15, 2007;
175(4):
306 - 311.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Kelly, J. Chakir, D. Vethanayagam, L.-P. Boulet, M. Laviolette, J. Gauldie, and P. M. O'Byrne
Montelukast treatment attenuates the increase in myofibroblasts following low-dose allergen challenge.
Chest,
September 1, 2006;
130(3):
741 - 753.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. F. Chung
The Role of Airway Smooth Muscle in the Pathogenesis of Airway Wall Remodeling in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
November 1, 2005;
2(4):
347 - 354.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 American Thoracic Society.
|
|
|